Statin use and breast cancer risk in a large population-based setting (Q36120856)

12 August 2017

Statin use and breast cancer risk in a large population-based setting (English)

1 reference

12 August 2017

1 reference

5

Susan R Heckbert

1 reference

12 August 2017

4

Diana S M Buist

1 reference

12 August 2017

3

Diana L Miglioretti

1 reference

12 August 2017

6

Janet R Daling

1 reference

12 August 2017

1

Denise M Boudreau

1 reference

12 August 2017

Onchee Yu

2

1 reference

PMCID

2065858

12 August 2017

language of work or name

1 reference

1 March 2007

1 reference

Cancer Epidemiology, Biomarkers & Prevention

12 August 2017

1 reference

12 August 2017

16

1 reference

12 August 2017

3

1 reference

12 August 2017

416-421

1 reference

Statin use and breast cancer: prospective results from the Women's Health Initiative.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

The influence of statin use on breast density

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

Statins and cancer development.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

Statins can inhibit proliferation of human breast cancer cells in vitro

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

The statins as anticancer agents

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

Statin use, hyperlipidaemia, and the risk of breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

The use of automated data to identify complications and comorbidities of diabetes: a validation study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

Carcinogenicity of lipid-lowering drugs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

Anti-carcinogenic activity of simvastatin during the promotion phase of radiation-induced mammary tumorigenesis of rats

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

Revisions in the risk-based Breast Cancer Screening Program at Group Health Cooperative.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

Serum lipids, lipid-lowering drugs, and the risk of breast cancer

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

Statin use and the risk of breast and prostate cancer

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective Study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2065858

Statins and breast cancer prevention: time for randomized controlled trials

5 December 2018

1 reference

12 December 2020

Lipophilic statins merit additional study for breast cancer chemoprevention

1 reference

12 December 2020

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study

1 reference

12 December 2020

Statin use and the risk of breast cancer

1 reference

12 December 2020

Evaluating organized breast cancer screening implementation: the prevention of late-stage disease?

1 reference

12 December 2020

A population-based osteoporosis screening program: who does not participate, and what are the consequences?

1 reference

12 December 2020

Impact of healthcare delivery system on where HMO-enrolled seniors purchase medications

1 reference

12 December 2020

Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis

1 reference

12 December 2020

Following positive epidemiologic studies, statins to enter clinical trials for cancer prevention

1 reference

12 December 2020

A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes

1 reference

12 December 2020

10.1158/1055-9965.EPI-06-0737

Identifiers

DOI

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

PMCID

2065858